Date Filed | Type | Description |
08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/26/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/25/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
07/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/13/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
07/13/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
06/16/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
06/09/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
06/08/2023 |
8-K
| Investor presentation |
05/15/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
03/02/2023 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
02/14/2023 |
SC 13G/A
| Venrock Healthcare Capital Partners II, L.P. reports a 5.6% stake in Savara Inc. |
02/14/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
01/20/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
12/15/2022 |
8-K
| Quarterly results |
11/21/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
08/26/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
06/03/2022 |
8-K
| Quarterly results |
05/11/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
04/22/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
04/19/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/19/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/30/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
03/30/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
02/14/2022 |
SC 13G/A
| CAXTON CORP reports a 6.1% stake in Savara Inc. |
02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2022 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 6% stake in Savara Inc. |
01/13/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
01/10/2022 |
8-K
| Investor presentation |
|